false
OasisLMS
Login
Catalog
2026 IASLC CT Screening and Early Detection Sympos ...
IASLC CT Screening and Early Detection Symposium ( ...
IASLC CT Screening and Early Detection Symposium (Ticketed)
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The workshop opened with an overview of the day’s agenda on lung cancer screening and early detection, covering biomarkers, never-smoker screening, broader health benefits, and AI. <br /><br />The first session focused on biomarkers. Speakers emphasized that biomarkers should be developed in the target population, using pre-diagnostic samples, adequate sample sizes, and independent validation cohorts. Blood-based protein biomarkers and radiomics were presented as promising tools, but speakers stressed that high AUC alone is not enough: calibration, clinical utility, cost-effectiveness, and implementation feasibility are essential. <br /><br />The never-smoker session highlighted that lung cancer is increasingly important in people who have never smoked, especially in Asia. Presentations showed that risk-based screening using family history, environmental exposures, and AI may identify high-risk never-smokers while avoiding overdiagnosis. A patient advocate shared a powerful personal story of being diagnosed after an incidental scan, underscoring the need for equitable screening access. <br /><br />The “beyond cancer detection” session explored incidental findings such as cardiovascular disease, COPD, emphysema, ILD, osteoporosis, and breast abnormalities. Speakers argued that low-dose CT can reveal major treatable comorbidities, but only if there are clear pathways for reporting, follow-up, and action. <br /><br />The AI session covered AI for nodule detection, malignancy prediction, workflow streamlining, and quantitative CT metrics. AI may help triage scans, reduce workload, and predict future risk, but must be externally validated and integrated carefully into clinical practice. <br /><br />The afternoon case review workshop illustrated how early lung cancer can mimic infection or benign disease, reinforcing the need for multidisciplinary assessment, prior imaging comparison, and structured training.
Meta Tag
Concept
Chest Screening
Concept
Biomarker Development
Concept
Biomarker Validation
Concept
Target Population
Concept
External Validation
Keywords
lung cancer screening
early detection
biomarkers
never-smoker screening
risk-based screening
low-dose CT
AI in radiology
radiomics
incidental findings
cardiovascular disease
COPD
nodule detection
clinical validation
overdiagnosis
multidisciplinary assessment
Chest Screening
Biomarker Development
Biomarker Validation
Target Population
External Validation
×
Please select your language
1
English